qa:qa_dcx-login
Xpert® C. difficile/Epi
45-minute detection of toxigenic Clostridioides difficile and presumptive identification of 027/NAP1/BI strains
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
10 Tests
GXCDIFF/EPI-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
Collection Device (Pack of 50)
900-0370
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Single Use Disposable Swab (Pack of 120)
SDPS-120
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
- Clostridioides difficile infection (CDI) accounts for 15–25% of healthcare-associated diarrhea cases in all healthcare settings1
- It is associated with an increase in length of hospital stay, high morbidity and mortality resulting in both societal and financial burden2
- Although the accurate and rapid diagnosis of CDI is essential for effective and timely treatment, this remains an unmet clinical need4
1 Lessa FC, Winston LG, McDonald LC, Emerging Infections Program C. difficile Surveillance Team Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:2369–2370.
2 Tschudin-Sutter S, et al. Guidance document for prevention of C. difficile infection in acute healthcare settings. Clin Microbiol Infect 2018;24:1051
4 Bai Y, Hao Y, Song Z, Chu W, Jin Y, Wang Y. Evaluation of the Cepheid Xpert C. difficile diagnostic assay: an update meta-analysis. Braz J Microbiol. 2021 Dec;52(4):1937-1949.
2 Tschudin-Sutter S, et al. Guidance document for prevention of C. difficile infection in acute healthcare settings. Clin Microbiol Infect 2018;24:1051
4 Bai Y, Hao Y, Song Z, Chu W, Jin Y, Wang Y. Evaluation of the Cepheid Xpert C. difficile diagnostic assay: an update meta-analysis. Braz J Microbiol. 2021 Dec;52(4):1937-1949.
The Solution
- The Xpert C. difficile/Epi test provides detection of toxigenic Clostridioides difficile and presumptive identification of 027/NAP1/BI strains, in 43 minutes from unformed stool specimens
- Rapid detection and differentiation of Clostridioides difficile (CDI) and the epidemic 027 strain optimizes patient management decisions and supports infection control and outbreak prevention measures
The Impact
- Rapid and accurate detection of toxigenic C. difficile is essential to diagnose CDI to implement optimized therapy and bed management and to help prevent transmission and outbreaks:
– 45% reduced empiric therapy5
– 48% reduced isolation days6
5 Peppard W, et al. Implementation of polymerase chain reaction to rule out C. difficile infection is associated with reduced empiric antibiotic duration of therapy. Hosp Pharm. 2014 Jul;49(7):639-43.
6 Casari E, et al. Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria. Antimicrob Resist Infect Control. 2018 Mar;7(40)
6 Casari E, et al. Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria. Antimicrob Resist Infect Control. 2018 Mar;7(40)
Related Products
Xpert vanA
The first rapid & accurate test to assist with VRE surveillance
Xpert MRSA NxG
Active MRSA surveillance testing in about an hour
Xpert MRSA/SA Blood Culture
Accurate detection of MRSA and SA in positive blood culture specimens in about an hour
Xpert Carba-R
Detection and differentiation of KPC, NDM, VIM, IMP-1, and OXA-48 in 48 minutes
Xpert C. difficile
Detection of Clostridioides difficile in 40 mintues*
Xpert MRSA/SA SSTI
Detect MRSA & SA Skin and Soft Tissue Infections In About One Hour
Xpert Norovirus
Fast and accurate identification of Norovirus GI & GII in as little as one hour* *With early assay termination for positive results. Reporting negative results in 90 minutes.
Xpert SA Nasal Complete
Pre-surgical S. aureus and MRSA in about an hour